Literature DB >> 28533418

HDAC1 links early life stress to schizophrenia-like phenotypes.

Sanaz Bahari-Javan1,2, Hristo Varbanov3, Rashi Halder4, Eva Benito4, Lalit Kaurani1, Susanne Burkhardt1, Heike Anderson-Schmidt1,5, Ion Anghelescu6, Monika Budde1,5, Roman M Stilling2, Joan Costa7, Juan Medina7, Detlef E Dietrich8, Christian Figge9, Here Folkerts10, Katrin Gade1,5, Urs Heilbronner1,5, Manfred Koller11, Carsten Konrad12, Sara Y Nussbeck13, Harald Scherk14, Carsten Spitzer15, Sebastian Stierl16, Judith Stöckel16, Andreas Thiel12, Martin von Hagen17, Jörg Zimmermann8,18, Antje Zitzelsberger10, Sybille Schulz18, Andrea Schmitt19,20, Ivana Delalle21, Peter Falkai1,20, Thomas G Schulze1,5, Alexander Dityatev3, Farahnaz Sananbenesi2, André Fischer22,4.   

Abstract

Schizophrenia is a devastating disease that arises on the background of genetic predisposition and environmental risk factors, such as early life stress (ELS). In this study, we show that ELS-induced schizophrenia-like phenotypes in mice correlate with a widespread increase of histone-deacetylase 1 (Hdac1) expression that is linked to altered DNA methylation. Hdac1 overexpression in neurons of the medial prefrontal cortex, but not in the dorsal or ventral hippocampus, mimics schizophrenia-like phenotypes induced by ELS. Systemic administration of an HDAC inhibitor rescues the detrimental effects of ELS when applied after the manifestation of disease phenotypes. In addition to the hippocampus and prefrontal cortex, mice subjected to ELS exhibit increased Hdac1 expression in blood. Moreover, Hdac1 levels are increased in blood samples from patients with schizophrenia who had encountered ELS, compared with patients without ELS experience. Our data suggest that HDAC1 inhibition should be considered as a therapeutic approach to treat schizophrenia.

Entities:  

Keywords:  HDAC inhibitor; early life stress; histone-deacetylases; personalized medicine; schizophrenia

Mesh:

Substances:

Year:  2017        PMID: 28533418      PMCID: PMC5468618          DOI: 10.1073/pnas.1613842114

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  78 in total

1.  DNA methyltransferase Dnmt1 associates with histone deacetylase activity.

Authors:  F Fuks; W A Burgers; A Brehm; L Hughes-Davies; T Kouzarides
Journal:  Nat Genet       Date:  2000-01       Impact factor: 38.330

2.  Relations between open-field, elevated plus-maze, and emergence tests as displayed by C57/BL6J and BALB/c mice.

Authors:  R Lalonde; C Strazielle
Journal:  J Neurosci Methods       Date:  2008-02-12       Impact factor: 2.390

Review 3.  Mitochondrial roles of the psychiatric disease risk factor DISC1.

Authors:  R Norkett; S Modi; J T Kittler
Journal:  Schizophr Res       Date:  2017-01-10       Impact factor: 4.939

4.  Fast gapped-read alignment with Bowtie 2.

Authors:  Ben Langmead; Steven L Salzberg
Journal:  Nat Methods       Date:  2012-03-04       Impact factor: 28.547

5.  How to design biospecimen identifiers and integrate relevant functionalities into your biospecimen management system.

Authors:  Sara Y Nussbeck; Daniela Skrowny; Sheila O'Donoghue; Thomas G Schulze; Krister Helbing
Journal:  Biopreserv Biobank       Date:  2014-06       Impact factor: 2.300

Review 6.  Targeting histone-modifications in Alzheimer's disease. What is the evidence that this is a promising therapeutic avenue?

Authors:  Andre Fischer
Journal:  Neuropharmacology       Date:  2014-01-31       Impact factor: 5.250

7.  Expression of GABA signaling molecules KCC2, NKCC1, and GAD1 in cortical development and schizophrenia.

Authors:  Thomas M Hyde; Barbara K Lipska; Towhid Ali; Shiny V Mathew; Amanda J Law; Ochuko E Metitiri; Richard E Straub; Tianzhang Ye; Carlo Colantuoni; Mary M Herman; Llewellyn B Bigelow; Daniel R Weinberger; Joel E Kleinman
Journal:  J Neurosci       Date:  2011-07-27       Impact factor: 6.167

8.  Molecular determinants of dysregulated GABAergic gene expression in the prefrontal cortex of subjects with schizophrenia.

Authors:  Nikolaos Mellios; Hsien-Sung Huang; Stephen P Baker; Marzena Galdzicka; Edward Ginns; Schahram Akbarian
Journal:  Biol Psychiatry       Date:  2009-01-01       Impact factor: 13.382

9.  Urbanicity, social adversity and psychosis.

Authors:  Andreas Heinz; Lorenz Deserno; Ulrich Reininghaus
Journal:  World Psychiatry       Date:  2013-10       Impact factor: 49.548

10.  HDAC2 negatively regulates memory formation and synaptic plasticity.

Authors:  Ji-Song Guan; Stephen J Haggarty; Emanuela Giacometti; Jan-Hermen Dannenberg; Nadine Joseph; Jun Gao; Thomas J F Nieland; Ying Zhou; Xinyu Wang; Ralph Mazitschek; James E Bradner; Ronald A DePinho; Rudolf Jaenisch; Li-Huei Tsai
Journal:  Nature       Date:  2009-05-07       Impact factor: 49.962

View more
  25 in total

Review 1.  Regulation of Central Nervous System Development by Class I Histone Deacetylases.

Authors:  Santosh R D'Mello
Journal:  Dev Neurosci       Date:  2020-01-24       Impact factor: 2.984

2.  PET neuroimaging reveals histone deacetylase dysregulation in schizophrenia.

Authors:  Tonya M Gilbert; Nicole R Zürcher; Christine J Wu; Anisha Bhanot; Baileigh G Hightower; Minhae Kim; Daniel S Albrecht; Hsiao-Ying Wey; Frederick A Schroeder; Anais Rodriguez-Thompson; Thomas M Morin; Kamber L Hart; Amelia M Pellegrini; Misha M Riley; Changning Wang; Steven M Stufflebeam; Stephen J Haggarty; Daphne J Holt; Marco L Loggia; Roy H Perlis; Hannah E Brown; Joshua L Roffman; Jacob M Hooker
Journal:  J Clin Invest       Date:  2018-12-10       Impact factor: 14.808

Review 3.  Neurobiological effects of aerobic exercise, with a focus on patients with schizophrenia.

Authors:  Isabel Maurus; Alkomiet Hasan; Astrid Röh; Shun Takahashi; Boris Rauchmann; Daniel Keeser; Berend Malchow; Andrea Schmitt; Peter Falkai
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2019-05-21       Impact factor: 5.270

Review 4.  A translational perspective on histone acetylation modulators in psychiatric disorders.

Authors:  Surajit Ganguly; Subhendu Seth
Journal:  Psychopharmacology (Berl)       Date:  2018-06-19       Impact factor: 4.530

Review 5.  GABAergic inhibitory neurons as therapeutic targets for cognitive impairment in schizophrenia.

Authors:  Meng-Yi Xu; Albert H C Wong
Journal:  Acta Pharmacol Sin       Date:  2018-03-22       Impact factor: 6.150

Review 6.  Epigenetics as a Biomarker for Early-Life Environmental Exposure.

Authors:  Rose Schrott; Ashley Song; Christine Ladd-Acosta
Journal:  Curr Environ Health Rep       Date:  2022-07-30

Review 7.  The shallow cognitive map hypothesis: A hippocampal framework for thought disorder in schizophrenia.

Authors:  Ayesha Musa; Safia Khan; Minahil Mujahid; Mohamady El-Gaby
Journal:  Schizophrenia (Heidelb)       Date:  2022-04-07

Review 8.  Histone deacetylase-3: Friend and foe of the brain.

Authors:  Santosh R D'Mello
Journal:  Exp Biol Med (Maywood)       Date:  2020-06-02

Review 9.  NMDA receptor hypofunction for schizophrenia revisited: Perspectives from epigenetic mechanisms.

Authors:  Melissa A Snyder; Wen-Jun Gao
Journal:  Schizophr Res       Date:  2019-04-09       Impact factor: 4.939

Review 10.  Caught in vicious circles: a perspective on dynamic feed-forward loops driving oxidative stress in schizophrenia.

Authors:  Michel Cuenod; Pascal Steullet; Jan-Harry Cabungcal; Daniella Dwir; Ines Khadimallah; Paul Klauser; Philippe Conus; Kim Q Do
Journal:  Mol Psychiatry       Date:  2021-11-10       Impact factor: 13.437

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.